TOKYO -- Japanese pharmaceutical and medical material makers are expanding domestic output of ingredients and production materials for vaccines in response to a creeping shortage of supplies globally.
COVID vaccines
Japan pharma cranks up output of COVID vaccine materials
Global supplies shortage and dependence on West spell urgency, opportunity
Takara Bio looks to put new reagents for mRNA vaccines on the market this fall. (Photo courtesy of Takara Bio)
Read Next
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on COVID vaccines
